| 3DEL: reference: Exploiting antigenic diversity for vaccine design: the Chlamydia ArtJ paradigm., Soriani M, Petit P, Grifantini R, Petracca R, Gancitano G, Frigimelica E, Nardelli F, Garcia C, Spinelli S, Scarabelli G, Fiorucci S, Affentranger R, Ferrer-Navarro M, Zacharias M, Colombo G, Vuillard L, Daura X, Grandi G, J Biol Chem. 2010 Jun 30. PMID: 20592031 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).